Introduction:
The elastomeric infusion pumps market size in 2026 is estimated at USD 0.85 billion, growing from 2025 value of USD 0.81 billion with 2031 projections showing USD 1.08 billion, growing at 4.89% CAGR over 2026-2031. Growth is fueled by the rising adoption of home-based care, supportive reimbursement policies for non-opioid pain management, and ongoing improvements in elastomeric membrane technology. North America currently leads the market, while Asia-Pacific shows the fastest growth as hospitals modernize and outpatient services expand.
Elastomeric infusion pumps are portable, mechanically simple devices that deliver a controlled flow of medication without the need for external power sources. Their use is increasing across hospital, ambulatory, and home-care settings, particularly for post-surgical analgesia, chronic disease management, and antibiotic therapy.
Key Trends in the Elastomeric Infusion Pumps Market
Several trends are shaping the elastomeric infusion pumps market growth:
-
Home Healthcare Expansion: Home-based infusion therapy is gaining momentum due to lower costs and patient preference for familiar environments. Portable, battery-free devices reduce caregiver training requirements, making them ideal for hospital-at-home programs.
-
Technological Improvements: Advancements in elastomeric membranes, including improved check-valve geometries, medical-grade silicone and polyisoprene blends, and temperature-stable additive packages, enhance accuracy and minimize leakage.
-
Rising Chronic Disease Prevalence: Aging populations and higher chronic disease incidence are driving demand for continuous antibiotic, immunoglobulin, and oncology therapies delivered via elastomeric pumps.
-
Outpatient Oncology Services: Hospitals and clinics are increasingly adopting elastomeric pumps for multi-day chemotherapy treatments, allowing patients to maintain normal activity during therapy.
-
Cost-Effectiveness Compared to Electronic Pumps: Elastomeric pumps offer economic advantages in cost-sensitive markets, supporting broader adoption where budget constraints exist.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation in the Elastomeric Infusion Pumps Market
The elastomeric infusion pumps market is segmented by product type, application, end-user, flow rate, and distribution channel.
-
By Product Type:
-
Continuous-Rate Pumps (largest share, favored for mechanical simplicity)
-
Variable-Rate Pumps
-
PCA (Patient-Controlled Analgesia) Pumps (growing steadily)
-
By Application:
-
Pain Management (dominant revenue share)
-
Antibiotic Therapy (expected strong growth)
-
Oncology and Other Therapeutic Areas
-
chemotherapy
-
By End User:
-
Hospitals (largest share)
-
Ambulatory Surgery Centers (ASCs)
-
Home Healthcare (fastest-growing segment)
-
Other Care Settings
-
By Flow Rate:
-
2–5 mL/h (majority share)
-
5 mL/h (high-growth segment)
-
By Distribution Channel:
-
Direct Sales (largest share)
-
Third-Party/Distributor Networks (strong growth forecast)
Key Players in the Elastomeric Infusion Pumps Market
The elastomeric infusion pumps market is moderately fragmented with a mix of global multinationals and specialized niche players. Companies focus on product reliability, ease of use, and membrane performance to maintain competitive positioning. Product recalls, regulatory oversight, and sustainability considerations influence market dynamics, and companies are increasingly emphasizing environmentally friendly designs. Key participants actively engage in expanding distribution channels and introducing fill-at-home solutions to address growing demand in home healthcare.
-
B. Braun Melsungen AG
-
Nipro Corporation
-
Leventon, S.A.U
-
Avanos Medical, Inc.
-
Baxter International Inc.
Conclusion:
The elastomeric infusion pumps market is set to witness steady growth over the forecast period, driven by the shift toward home-based care, the rising prevalence of chronic diseases, and supportive reimbursement policies. Continuous-rate pumps remain the most widely adopted, while PCA and high-flow devices gain attention in specialty applications. Geographic trends show North America retaining market leadership, whereas Asia-Pacific is poised for rapid expansion due to healthcare infrastructure modernization and outpatient therapy adoption.
With ongoing improvements in elastomeric membranes and device designs, the market offers opportunities for both established and emerging players. Growth in hospital-at-home programs, outpatient oncology services, and antibiotic therapy applications will continue to shape the elastomeric infusion pumps market share and influence strategic developments through 2030.
Industry Related Reports:
Infusion Pumps And Accessories Market : The Infusion Pumps and Accessories Market Report Segments the Industry Into by Product Type (Infusion Pump Types, Accessories/Disposables), by Application (Gastroenterology, Diabetes Management, Hematology, Other Applications), by End User (Hospitals, Ambulatory Surgery Center, Other End Users) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Europe Insulin Infusion Pumps Market : The Market Report Covers Europe Insulin Pump Manufacturers and is Segmented by Component (insulin Pumps, Infusion Sets, And Reservoirs) and Geography (France, Germany, Italy, Spain, The United Kingdom, Russia, And the Rest of Europe).
Asia-Pacific Insulin Infusion Pumps Market: The Asia-Pacific Insulin Infusion Pumps Market is Segmented by Components (insulin Pump Device, Infusion Set, and Reservoir) and Geography (Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, The Philippines, Thailand, and the Rest of Asia-Pacific).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/
